ZM-003

N/A

Report date: 2025/01/26 17:01:44
NME

Base Information

Drug NameZM-003
Drug Alias NameKCNQ2/3 Potassium Channel Activators (Protheragen)ZM-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 agonistsPotassium voltage-gated channel subfamily KQT member 3 stimulants
TargetsPotassium voltage-gated channel subfamily KQT member 3Voltage-gated potassium channel subunit Kv7.2
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProtheragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesProtheragen Inc
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A